There is an article in last week's Las Vegas Review Journal on the device. I had read about it, but it sounded so unbelievable... electric fields that disrupt cancer cell division in glioblastomas.
However, it seems to be effective. The article states it costs 21K monthly and is reimbursed by insurance. I do read where it is to be used along with chemo. Survival went from 2 to 6 months. That's impressive!
One of my stocks is due to report phase one results in a trial using targeted chemo against gliobastomas based on animal studies conducted by Dr. Nicholas Butowski, M.D., Associate Professor of Neurological Surgery and Principal Investigator of the study at the University of California. UCA is sponsoring the trial.
https://clinicaltrials.gov/ct2/show/...=MM-398&rank=5